What is the ticker symbol for Hemab Therapeutics?

Hemab Therapeutics trades under the ticker COAG on NASDAQ.

What sector does Hemab Therapeutics operate in?

Hemab Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze COAG in a portfolio?

PortView shows COAG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Hemab Therapeutics (COAG) Stock Analysis

NASDAQHealthcareBiotechnology

$42.85-2.67%

1-year price historyRange $24.98 – $54.94

52-week range$42.85

$23.00$55.42

What Hemab Therapeutics does

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$2.00B

P/E (TTM)

-1.79

EPS (TTM)

$-23.98

Beta

1.85

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$44.30

200-day avg

$37.12

52-week high

$55.42

52-week low

$23.00

CEO

Benny Sorensen

ETFs linked to COAG

Broad-market and Healthcare sector ETFs an investor holding Hemab Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how COAG fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze COAG in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Hemab Therapeutics?: Hemab Therapeutics trades under the ticker COAG on NASDAQ.
Which exchange is COAG listed on?: COAG is listed on NASDAQ.
What sector does Hemab Therapeutics operate in?: Hemab Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze COAG in a portfolio?: PortView shows COAG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.